I don't think we'll need to wait for more announcements. October has seen every market in the world oversold. There is high pessimism at the moment, so everything is a bit slow, especially with speculative stocks. The Asian markets have oversold the most. But with overselling comes overbuying. Given the high volatility in October, its very likely that the American Feds will soften their narrative at the next quarterly meeting, perhaps even lower their interest rates. Financial experts expect it to be bullish in November all the way to new years.
Today its slowed, and as Ivan indicated, looking at the recent trends, it looks like we're at the lowest trough (fingers crossed). So based on those facts, it seems likely that the price will rise again, because honestly, what do you value this company at atm? An in-house product thats proven to work. Seeking out industry experts to evaluate their product; ONLY seeking out influential industry experts. With Monash, the leading IVF group in Australia supporting their commerialisation process. I'd say these guys are worth at least 10 cents atm. After their successful clinical trials at the end of quarter one 2019, I'd say at least 30 cents. Once they start selling the product in Australia, at least 50 cents.
This is all IMO. Dont make financial decisions based on the words of a psychologist. But it does seem positive at the moment.
